SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications -- Psoriasis/Chronic Inflammation
An SI Board Since February 2001
Posts SubjectMarks Bans
631 42 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
306DCGN / gene linked to psoriatic arthritis REYKJAVIK, Iceland, Dec. 13 /PRNewswinigel bates-12/13/2002
305Arthritis Rheum 2002 Nov;46(11):3076-82 Spinal adenosine receptor activation iscaram(o)uche-12/8/2002
304Serono / TBP-1 LONDON, Dec 2 (Reuters) - Swiss-based Serono SA (SEOZ.VX) said onigel bates-12/2/2002
303Celltech Announces Receipt of CDP 870 Phase III Milestone Payment From Pharmaciascaram(o)uche-11/26/2002
302Early Results Suggest Alefacept Plus Light Therapy May Clear Psoriasis CAMscaram(o)uche-11/22/2002
301J. Clin. Invest. 110:1419-1427 (2002). doi:10.1172/JCI200215582. Copyright ©Miljenko Zuanic-11/18/2002
300First acrylamides, now 'AGE's. It getting so that eating is no fun anymnigel bates-11/12/2002
299Arriva-ProMetic Recombinant Alpha 1-Antitrypsin (rAAT) Moves into the Clinic forrusset-11/7/2002
298[ anti-IL-6R MAb/Chugai/RA ] Chugai drug shows promise in rheumatoid arthritis scaram(o)uche-10/29/2002
297I've followed the issue pretty closely. Dr. Allison at Berkeley is an acquascaram(o)uche-10/26/2002
296CTLA4 - IP The IP surrounding CTLA4 seems to be somewhat messy. Apart from BMS Icebrg-10/26/2002
295Data Show Bristol-Myers Squibb's BMS-188667 (CTLA4Ig), An Investigational Coscaram(o)uche-10/26/2002
294Data Suggest Bristol-Myers Squibb Investigational Costimulation Blocker, BMS-188scaram(o)uche-10/26/2002
293Cancer drug Rituxan combats arthritis, study shows Friday October 25, 6:32 pm ETIcebrg-10/25/2002
292Trials show new arthritis drug safe and effective Friday October 25, 6:00 pm ET Icebrg-10/25/2002
291Market is growing....http://biz.yahoo.com/prnews/021022/netu032_1.htmlArthur Radley-10/22/2002
290[ LFA3tip/Biogen ] Arthritis Rheum 2002 Oct;46(10):2776-84 Alefacept treatmentscaram(o)uche-10/21/2002
289LFA-1 Novartis ZURICH, Oct 18 (Reuters) - Novartis AG (NOVZn.VX) has agreed to nigel bates-10/18/2002
288LFA-1 Antagonist (from Biogen's Q3 report) Biogen and ICOS Corporation are Icebrg-10/18/2002
287CLL / CDP870 / Crohn's SLOUGH, England, Oct. 17 /PRNewswire-FirstCall/ -- Cnigel bates-10/17/2002
286Amgen and Wyeth Pharmaceuticals Announce Initiation of Landmark Study in RheumatIcebrg-10/17/2002
285Centocor Expands Research and Development to Focus on Immune-Mediated InflammatoIcebrg-10/17/2002
284Apoptotic DNA 10/14/2002 -- Scientists have discovered that the presence of undnigel bates-10/15/2002
283DGEN / DT044I (new target) REDWOOD CITY, Calif., Oct. 11 /PRNewswire-FirstCall/nigel bates-10/11/2002
282Full text free Anti TNF in P.Arthritis www2.eskinandallergynews.comaknahow-10/4/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News